Details of the Drug
General Information of Drug (ID: DMT8KHO)
| Drug Name |
Radiolabeled onartuzumab
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
Onartuzumab-[76Br]; Onartuzumab-[89Zr]; Bromine-76-onartuzumab; Radiolabeled onartuzumab (imaging, cancer); Zirconium-89-onartuzumab; Radiolabeled MetMab (humanized mAb, cancer), Genentech; Radiolabeled onartuzumab (imaging, cancer), Genentech; 76Br-MetMab; 76Br-labeled MetMab (humanized mAb, cancer), Genentech; 76Br-onartuzumab; 89Zr-MetMab; 89Zr-labeled MetMab (humanized mAb, PET contrast agent), Genentech; 89Zr-onartuzumab
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Drug Type |
Monoclonal antibody
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||